The Union's Offices
The Union’s headquarters in Paris is the global cornerstone of the organisation, taking on a coordinating role, sets policy and provides financial oversight of the organisation. The Union Switzerland Office, based in Geneva, acts as the political convenor for The Union, working at a strategic level to influence global health policy through high-level discussion and partnership.
The Union has worked in Europe since 2006, providing grants and technical support to organisations working on tobacco control activities through the Bloomberg Initiative to Reduce Tobacco Use (BI) Grants Program.
Members of The Union Europe Region
The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues.
The Union Europe Region is made up of individuals and organisations.
Members in Europe initiated the first dedicated region Scientific Track, held at the Union World Conference on Lung Health. The sessions, developed in partnership with members of The Union’s Europe Region, shared experiences and challenges that are specific to the continent and invited delegates to focus on TB and lung health concerns that are particularly pressing in Europe.
UNION NEWS FROM THE Europe REGION
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022
A Letter in a forthcoming issue of the IJTLD highlights the impact of the war in Ukraine on TB services. The preprint is free to read.
Correspondence in a forthcoming issue of IJTLD examines the impact of the war in Ukraine on healthcare systems in the area, including both Eastern and non-Eastern European countries and future management of TBI and TB disease. The preprint is free to read.
COVID-19 and poor air quality is leading to increased use of mechanical ventilation, but the authors of this article question how effective these systems are in important buildings in India. The preprint is free to read.
The authors have monitored post-arrival screening for COVID-19 to evaluate its effectiveness. The preprint is free to read.